Alternaria IgG precipitins and adverse reactions.
Late reactions consisting of fever, malaise, and swelling at the site, 4 to 6 hr after injections of Alternaria extract occurred in several patients receiving immunotherapy with Alternaria. These patients had in common serum IgG precipitins and exquisite leukocyte histamine release sensitivity to Alternaria. Such precipitins were 3 times more frequent in patients receiving Alternaria immunotherapy than a control group of patients receiving immunotherapy with other antigens. A prospective study revealed that 5 of 23 Alternaria-sensitive persons had precipitins before immunotherapy and another 6 developed precipitins during therapy. Only one of the 23 experienced a late Alternaria reaction. Thus, precipitins to Alternaria are common and do not seem to be the basis for the late reactions we observed. The finding of precipitins does not contraindicate immunotherapy.
D000528:Alternaria / Q000276:immunology*; D000908:Antibodies, Fungal / Q000032:analysis; D006636:Histamine Release; D006801:Humans; D006967:Hypersensitivity / Q000276:immunology; D007073:Immunoglobulin E / Q000032:analysis; D007074:Immunoglobulin G; D007167:Immunotherapy / Q000009:adverse effects*; D003904:Mitosporic Fungi / Q000276:immunology*; D011234:Precipitins / Q000032:analysis*; D011446:Prospective Studies
D000908:Antibodies, Fungal; D007074:Immunoglobulin G; D011234:Precipitins; D007073:Immunoglobulin E